Lexicon Pharmaceuticals, Inc. logo

Lexicon Pharmaceuticals, Inc.

NASDAQ:LXRX

Overview | Financials
Company Name Lexicon Pharmaceuticals, Inc.
Symbol LXRX
Currency USD
Price 1.64
Market Cap 592,846,880
Dividend Yield 0%
52-week-range 0.92 - 3.73
Industry Biotechnology
Sector Healthcare
CEO Mr. Lonnel Coats
Website https://www.lexpharma.com

An error occurred while fetching data.

About Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase

Related Stocks

AlloVir, Inc. logo

AlloVir, Inc.

ALVR

0.76 USD

Dyne Therapeutics, Inc. logo

Dyne Therapeutics, Inc.

DYN

34.34 USD

4D Molecular Therapeutics, Inc. logo

4D Molecular Therapeutics, Inc.

FDMT

16.82 USD

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.

CLPT

11.66 USD

Financials

Numbers are in millions USD

Numbers are in millions USD